These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 17004249

  • 1. Early immunosuppression withdrawal after living donor liver transplantation and donor stem cell infusion.
    Donckier V, Troisi R, Le Moine A, Toungouz M, Ricciardi S, Colle I, Van Vlierberghe H, Craciun L, Libin M, Praet M, Noens L, Stordeur P, Andrien M, Lambermont M, Gelin M, Bourgeois N, Adler M, de Hemptinne B, Goldman M.
    Liver Transpl; 2006 Oct; 12(10):1523-8. PubMed ID: 17004249
    [Abstract] [Full Text] [Related]

  • 2. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
    Donckier V, Troisi R, Toungouz M, Colle I, Van Vlierberghe H, Jacquy C, Martiat P, Stordeur P, Zhou L, Boon N, Lambermont M, Schandené L, Van Laethem JL, Noens L, Gelin M, de Hemptinne B, Goldman M.
    Transpl Immunol; 2004 Oct; 13(2):139-46. PubMed ID: 15380544
    [Abstract] [Full Text] [Related]

  • 3. Repeating intraportal donor-specific transfusion may induce tolerance following adult living-related donor liver transplantation.
    Sato Y, Ichida T, Watanabe H, Yamamoto S, Oya H, Nakatsuka H, Kobayashi T, Watanabe T, Kameyama H, Hatakeyama K.
    Hepatogastroenterology; 2003 Oct; 50(51):601-6. PubMed ID: 12828042
    [Abstract] [Full Text] [Related]

  • 4. Acute liver transplant rejection upon immunosuppression withdrawal in a tolerance induction trial: potential role of IFN-gamma-secreting CD8+ T cells.
    Donckier V, Craciun L, Lucidi V, Buggenhout A, Troisi R, Rogiers X, Boon N, Gustot T, Moreno C, Bourgeois N, Colle I, Van Vlierberghe H, Nagy N, Praet M, Dernies T, Amrani M, Stordeur P, de Hemptinne B, Goldman M.
    Transplantation; 2009 May 15; 87(9 Suppl):S91-5. PubMed ID: 19424019
    [Abstract] [Full Text] [Related]

  • 5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May 15; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 6. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR, Huang CW, Goto S, Wang CT, Hsu LW, Lin YC, Yang KD, Chen CL, Lee WP.
    J Surg Res; 2009 May 15; 153(2):317-25. PubMed ID: 19101689
    [Abstract] [Full Text] [Related]

  • 7. Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation.
    Koshiba T, Li Y, Takemura M, Wu Y, Sakaguchi S, Minato N, Wood KJ, Haga H, Ueda M, Uemoto S.
    Transpl Immunol; 2007 Feb 15; 17(2):94-7. PubMed ID: 17306739
    [Abstract] [Full Text] [Related]

  • 8. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A, Nart A, Taşli FA, Postaci H, Aykas A, Doğan M, Sahin T.
    Nephrology (Carlton); 2008 Feb 15; 13(1):80-6. PubMed ID: 18199109
    [Abstract] [Full Text] [Related]

  • 9. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R, Cinti P, Lai Q, Poli L, Berloco PB.
    Transpl Immunol; 2008 Nov 15; 20(1-2):3-5. PubMed ID: 18773959
    [Abstract] [Full Text] [Related]

  • 10. Tolerance induction in clinical transplantation.
    Fehr T, Sykes M.
    Transpl Immunol; 2004 Nov 15; 13(2):117-30. PubMed ID: 15380542
    [Abstract] [Full Text] [Related]

  • 11. Macrochimerism of donor type CD56+ CD3+ T cells in donor specific transfusion via portal vein following living related donor liver transplantation.
    Sato Y, Ichida T, Watanabe H, Yamamoto S, Abo T, Hatakeyama K.
    Hepatogastroenterology; 2003 Nov 15; 50(54):2161-5. PubMed ID: 14696487
    [Abstract] [Full Text] [Related]

  • 12. Induction of tolerance in solid organ transplantation: the rationale to develop clinical protocols in liver transplantation.
    Donckier V, Sanchez-Fueyo A, Craciun L, Lucidi V, Buggenhout A, Troisi R, Rogiers X, Bourgeois N, Boon N, Moreno C, Colle I, Van Vlierberghe H, de Hemptinne B, Goldman M.
    Transplant Proc; 2009 Mar 15; 41(2):603-6. PubMed ID: 19328936
    [Abstract] [Full Text] [Related]

  • 13. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
    Heinzelmann F, Lang PJ, Ottinger H, Faul C, Bethge W, Handgretinger R, Bamberg M, Belka C.
    Int J Radiat Oncol Biol Phys; 2008 Feb 01; 70(2):523-8. PubMed ID: 17869449
    [Abstract] [Full Text] [Related]

  • 14. A multiplex bead array analysis to monitor donor-specific cytokine responses after withdrawal of immunosuppression in HLA-identical living related kidney transplant patients.
    Gerrits JH, van de Wetering J, van Beelen E, Claas FH, Weimar W, van Besouw NM.
    Transplant Proc; 2009 Jun 01; 41(5):1577-82. PubMed ID: 19545683
    [Abstract] [Full Text] [Related]

  • 15. Long-term follow-up of donor chimerism and tolerance after human liver transplantation.
    Ayala R, Grande S, Albizua E, Crooke A, Meneu JC, Moreno A, Pérez B, Gilsanz F, Moreno E, Martínez-Lopez J.
    Liver Transpl; 2009 Jun 01; 15(6):581-91. PubMed ID: 19479801
    [Abstract] [Full Text] [Related]

  • 16. A rapid test of alloreactivity based on interleukin-2 mRNA expression might identify liver transplant recipients with donor-specific hyporesponsiveness.
    Craciun L, Stordeur P, Troisi R, Le Moine A, Toungouz M, Colle I, Van Vlierberghe H, Loi P, Lucidi V, Praet M, de Hemptinne B, Goldman M, Donckier V.
    Transplant Proc; 2007 Oct 01; 39(8):2665-7. PubMed ID: 17954202
    [Abstract] [Full Text] [Related]

  • 17. Donor bone marrow transplantation: chimerism and tolerance.
    Delis S, Ciancio G, Burke GW, Garcia-Morales R, Miller J.
    Transpl Immunol; 2004 Oct 01; 13(2):105-15. PubMed ID: 15380541
    [Abstract] [Full Text] [Related]

  • 18. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
    Li S, Salgar SK, Kurimoto Y, Yousem S, Pham SM.
    J Surg Res; 2008 May 15; 146(2):289-97. PubMed ID: 18314139
    [Abstract] [Full Text] [Related]

  • 19. Operational tolerance in clinical liver transplantation: emerging developments.
    Tisone G, Orlando G, Angelico M.
    Transpl Immunol; 2007 Feb 15; 17(2):108-13. PubMed ID: 17306741
    [Abstract] [Full Text] [Related]

  • 20. Minimization of immunosuppression with thymoglobuline pre-treatment and HCV recurrence in liver transplantation.
    De Ruvo N, Cucchetti A, Lauro A, Masetti M, Di Benedetto F, Cautero N, La Barba G, Dazzi A, Di Francesco F, Molteni G, Romano A, Ramacciato G, Risaliti A, Pinna AD.
    Clin Transplant; 2005 Apr 15; 19(2):255-8. PubMed ID: 15740564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.